HealthCap
HealthCap
  • About
    • Our Story
    • Strategy
    • ESG Policy
    • Partners
    • Team
    • Special Advisors
  • 1996 – 2021
  • Investments
    • Portfolio Companies
    • Approved Products
  • News
    • Portfolio Companies
    • HealthCap
  • Contact & Legal
    • Contact Us
    • Privacy Policy
    • Cookie Policy
  • LinkedIn
  • Wikipedia

HealthCap

General

Q4 2022 General Market Overview

Q3 2022 General Market Overview

Q2 2022 General Market Overview

Q1 2022 General Market Overview

Q4 2021 General Market Overview

Q3 2021 General Market Overview

Q2 2021 General Market Overview

Q1 2021 General Market Overview

Q4 2020 General Market Overview

Q3 2020 General Market Overview

Q2 2020 General Market Overview

Q1 2020 General Market Overview

Q4 2019 General Market Overview

Q3 2019 General Market Overview

Q2 2019 General Market Overview

Q1 2019 General Market Overview

Q4 2018 General Market Overview

Q3 2018 General Market Overview

Q2 2018 General Market Overview

Q1 2018 General Market Overview

Q4 2017 General Market Overview

Q3 2017 General Market Overview

Q2 2017 General Market Overview

Q1 2017 General Market Overview

Q4 2016 General Market Overview

Q3 2016 General Market Overview

Q2 2016 General Market Overview

Q1 2016 General Market Overview

Q4 2015 General Market Overview

Q3 2015 General Market Overview

Q2 2015 General Market Overview

Q1 2015 General Market Overview

Q4 2014 General Market Overview

Q3 2014 General Market Overview

Q2 2014 General Market Overview

Q1 2014 General Market Overview

Q4 2013 General Market Overview

Q3 2013 General Market Overview

Q2 2013 General Market Overview

Q1 2013 General Market Overview

Material

Artikel i Life Science Sweden

HealthCap strengthens senior team

HealthCap senior advisor Frank J. Caufield has passed away at the age of 80

SVCA:s pris för Årets affär går till HealthCap VI LP för sin avyttring av Wilson Therapeutics AB

HealthCap gästar Stockholm Corporate Finance Life Science/Healthcaredag den 10 mars 2016

Appointment of Mr. Hans Schikan to HealthCap senior advisor

HealthCap Investor Seminar

HealthCap opens office in Oslo and Ludvik Sandnes appointed as Special Advisor

Appointment of Mr. Andrew Kay to HealthCap Senior Advisor

HealthCap awarded SVCA’s Deal of the Year

HealthCap i unikt samarbetsprojekt “Agenda för hälsa och välstånd”

HealthCap Presentation Farmasidagene 2014 Oslo

The Importance of Venture Capital (Swedish)

The Investor’s Perspective on Life Science Investments.

Venture Capital for Health and Economic Growth-Almedalen (Swedish)

Venture Capital for Breakthrough Therapies

This site uses cookies. But first we need your consent. More info.

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close